Elanco Animal Health NYSE: ELAN reported second-quarter 2026 revenue of $1.368 billion, up 10% on a

Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Author

Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spr

Amundi lifted its holdings in Elanco Animal Health Incorporated (NYSE: ELAN) by 101.9% in the first

On August 06, 2026, Elanco Animal Health Inc (ELAN) shares fell 7.7% to $24.20, continuing a challen

Elanco Animal Health President and CEO Jeff Simmons discusses what's behind the company's increased

UBS analyst Andrea Alfonso maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the p

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Add

Keybanc analyst Steve Dechert maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and r

Elanco Animal Health Incorporated (ELAN) Q2 2026 Earnings Call Transcript

Elanco Animal Health Incorporated (NYSE:ELAN) delivered strong financial performance for the second

Elanco beat second-quarter estimates, raised 2026 guidance and cited strong Pet Health demand, Zenre

Although the revenue and EPS for Elanco Animal Health (ELAN) give a sense of how its business perfor

US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies re

Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.34 per share, beatin

Elanco Animal Health (NYSE:ELAN) is looking for Q3 Adj EPS of $0.19-$0.22 vs $0.20 analyst estimate.

Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.03-$1.09 to $1.10-$1.16 vs $

Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target Second

Report highlights Elanco's impact through innovation, expanded access to animal care, a stronger and

On July 29, 2026, Elanco Animal Health Inc (ELAN) shares rose 3.4% to $26.39, continuing a positive

Elanco Animal Health (ELAN) possesses the right combination of the two key ingredients for a likely

California Public Employees Retirement System cut its stake in shares of Elanco Animal Health Incorp

Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Equal-Weight

Does Elanco Animal Health Incorporated (ELAN) have what it takes to be a top stock pick for momentum

Newly Published Data Found Credelio Quattro:Faster2 Tick1 Speed of Kill: Credelio Quattro is the onl

Published Data Shows that the Active Ingredient, Lotilaner, in Credelio Quattro: Kills existing blac

Allspring Global Investments Holdings LLC acquired a new position in Elanco Animal Health Incorporat

Elanco Animal Health (ELAN) has an impressive earnings surprise history and currently possesses the

Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax t

TD Cowen analyst Steve Scala maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the

Elanco Animal Health Incorporated (NYSE:ELAN) today announced plans to establish Elanco Ventures, a

TruCan Ultra Lyme-L4 is the first and only 1/2 mL combination vaccine protecting against both Lyme d

Company offers portfolio of treatment options and expert guidance following first confirmed case in 

Cramer says Zoetis has issues. Prefers this stock in animal health industry. Energy Transfer is in a

Elanco Animal Health Incorporated (NYSE:ELAN) today announced the phased launch of Befrena™ (tirnove

Citigroup analyst Daniel Grosslight maintains Elanco Animal Health (NYSE:ELAN) with a Buy and rai

JP Morgan analyst Chris Schott maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and r

Elanco Animal Health rallies after emergency use approvals and Q1 earnings beat, with higher guidanc

Elanco Animal Health (NYSE:ELAN) is looking for Q2 Adj EPS of $0.25-$0.28 vs $0.29 analyst estimate.

Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.00-$1.06 to $1.03-$1.09 vs $

Elanco Animal Health (NYSE:ELAN) reported quarterly earnings of $0.40 per share which beat the analy

Action Prepares Veterinarians and Livestock Producers with Prevention and Treatment Options Prior to

Citigroup analyst Daniel Grosslight initiates coverage on Elanco Animal Health (NYSE:ELAN) with a